Search
Search Results
-
Acinetobacter baumannii
Bacteria of the genus Acinetobacter is abundant and widespread in nature. They can be found in the environment (soil and water samples) and samples...
-
Pseudomonas, Burkholderia and Acinetobacter
Pseudomonas and related bacteria belong to the family Pseudomonadaceae, which contains over 200 species. Most of them are pathogenic to plants,...
-
Rapid detection of cefiderocol susceptibility/resistance in Acinetobacter baumannii
PurposeDue to its ability to disseminate worldwide and its multiple resistance trait, Acinetobacter baumannii is becoming a threat for public health...
-
Acinetobacter baumannii Virulence Factors and Biofilm Components: Synthesis, Structure, Function, and Inhibitors
Acinetobacter baumannii (A. baumannii) is a Gram-negative opportunistic human pathogen, and the drastic dissemination of multidrug resistance in A....
-
Isolation and characterization of three novel Acinetobacter baumannii phages from Beninese hospital wastewater
Acinetobacter baumannii is an opportunistic pathogen that is mostly associated with hospital-acquired infections. The rapid emergence of multi- and...
-
Molecular epidemiology of Acinetobacter baumannii complex causing invasive infections in Korean children during 2001–2020
BackgroundAcinetobacter baumannii (AB) has emerged as one of the most problematic pathogens affecting critically ill patients. This study aimed to...
-
Isolation and genome-wide analysis of the novel Acinetobacter baumannii bacteriophage vB_AbaM_AB3P2
A lytic Acinetobacter baumannii phage, isolate vB_AbaM_AB3P2, was isolated from a sewage treatment plant in China. A. baumannii phage vB_AbaM_AB3P2...
-
Biological characterization and genomic analysis of Acinetobacter baumannii phage BUCT628
Acinetobacter baumannii is an opportunistic pathogen that is resistant to the most commonly used antibiotics. In this study, the Acinetobacter phage...
-
Prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: a systematic review and meta-analysis
IntroductionThe development of colistin resistance in Acinetobacter baumannii during treatment has been identified in certain patients, often...
-
Co-regulation of biofilm formation and antimicrobial resistance in Acinetobacter baumannii: from mechanisms to therapeutic strategies
In recent years, multidrug-resistant Acinetobacter baumannii has emerged globally as a major threat to the healthcare system. It is now listed by the...
-
Evolution, control and success of combination therapy with Ampicilin-sulbactam/Ceftazidime-Avibactam during a Carbapenem-Resistant Acinetobacter baumannii outbreak in burn Intensive Care Unit
We present our findings on interpatient transmission, epidemic control measures, and the outcomes of a series of ten critically ill burn patients who...
-
Designing of multi-epitope peptide vaccine against Acinetobacter baumannii through combined immunoinformatics and protein interaction–based approaches
Acinetobacter baumannii is one of the major pathogenic ESKAPE bacterium, which is responsible for about more than 722,000 cases in a year, globally....
-
Different Efflux Pump Systems in Acinetobacter baumannii and Their Role in Multidrug Resistance
Several infections, such as pneumonia, urinary tract infections (UTIs), as well as bloodstream, skin, and soft tissue infections, are caused by...
-
The saclayvirus Aci01-1 very long and complex fiber and its receptor at the Acinetobacter baumannii surface
The Acinetobacter baumannii bacteriophage Aci01-1, which belongs to the genus Saclayvirus of the order Caudoviricetes , has an icosahedral head and a...
-
Dissemination of ArmA- and OXA-23-co-producing Acinetobacter baumannii Global Clone 2 in Switzerland, 2020–2021
Following the observation of an increased number of isolation of OXA-23- and ArmA-producing Acinetobacter baumannii at the national level, our aim...
-
Acinetobacter baumannii: assessing susceptibility patterns, management practices, and mortality predictors in a tertiary teaching hospital in Lebanon
BackgroundAcinetobacter baumannii is a major nosocomial pathogen capable of causing life-threatening infections. This bacterium is highly resistant...
-
In vitro and in vivo efficacy of cefiderocol plus tigecycline, colistin, or meropenem against carbapenem-resistant Acinetobacter baumannii
We investigated activities of cefiderocol combination therapy against carbapenem-resistant Acinetobacter baumannii (CR-AB). A total of 123 clinical...
-
Genomic analysis of Acinetobacter phage BUCT629, a newly isolated member of the genus Obolenskvirus
A new virulent Acinetobacter phage, BUCT629 (GenBank no. MZ712044.1), was isolated from hospital sewage. Next-generation sequencing (NGS) results...
-
Two peptides derivate from Acinetobacter baumannii outer membrane protein K as vaccine candidates: a comprehensive in silico study
BackgroundThe lack of appropriate vaccines is an obstacle to the effective management of A. baumannii infections. Peptide vaccines offer an...
-
Derivation and validation of a predictive mortality model of in-hospital patients with Acinetobacter baumannii nosocomial infection or colonization
PurposeAcinetobacter baumannii (Ab) is a Gram-negative opportunistic bacterium responsible for nosocomial infections or colonizations. It is...
